Result
You are eligible to use
Weekly Dose is 0 mg
Doses per pen is 0
12 weeks pens is 0
-
Reference: Sogroya® SmPC
-
To report any side effect(s) please contact the National
Pharmacovigilance Centre (NPC):
-
To report any side effect(s) or for more medical info please contact
us:
-
For more information about the product, please refer to the last
approved Summary of product characteristics in KSA on Saudi Drugs
Information system
-
In the event that there are comments on this materials, please
contact SFDA:
-
The content of this platform is intended for healthcare professional
use only, and should not be accessible to the public
-
SA24SOM00064
